YOLFTbeta
60

Zhejiang Shengda Pharm

603079 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

11.42CNY-0.20 (-1.72%)

Price History

Full chart

Market Stats

Previous Close11.62
Open11.83
Day Range11.42 – 11.83
52-Week Range9.94 – 22.00
Volume2.50M
Market Cap2.57B
P/E (TTM)56.71
Forward P/E0.00
EPS0.24
Dividend Yield0.73%
Beta0.33
50-Day Avg12.54
200-Day Avg15.43

About

Zhejiang Shengda Bio-Pharm Co., Ltd. engages in the developing, producing, and selling of food and feed additives in China and internationally. The company offers vitamins, such as biotin and folic acid; biopreservatives and functional ingredients, including nisin, natamycin, polylysine, and sucrose fermentation products; and intermediate APIs. It serves pharmaceutical, nutritional, food, and animal feed industries. The company was incorporated in 1999 and is headquartered in Tiantai, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMs. Jing Zhu
  • Employees1.08K
  • HeadquartersNo. 18 , Shifeng East Road, Tiantai, China, 317200, China
  • Websitehttps://www.sd-pharm.com

Leadership

  • Ms. Jing ZhuDeputy General Manager · b. 1986
  • Ms. Chao LiangGM & Head of Accounting · b. 1988
  • Mr. Xiang Xiao XuActing Board Secretary, CFO & Accounting Supervisor · b. 1980
  • Mr. Xiao XieDeputy General Manager · b. 1986
  • Ms. Chaoqun HongDeputy General Manager · b. 1987

Financials

Income Statement

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue449.25M398.77M380.90M536.43M482.15M508.56M492.71M519.15M867.31M789.73M738.02M727.41M827.40M844.54M
Growth (%)--11.24%-4.48%+40.83%-10.12%+5.48%-3.12%+5.37%+67.06%-8.95%-6.55%-1.44%+13.75%+2.07%
Cost of Revenue228.83M264.24M244.74M264.35M310.79M317.44M335.60M345.40M412.22M573.41M627.75M653.22M663.80M623.66M
Gross Profit220.43M134.53M136.16M272.08M171.36M191.12M157.11M173.75M455.09M216.33M110.27M74.18M163.60M220.87M
Gross Margin49.06%33.74%35.75%50.72%35.54%37.58%31.89%33.47%52.47%27.39%14.94%10.20%19.77%26.15%
Operating Expense128.98M87.82M85.58M162.24M108.27M105.30M104.81M123.06M207.79M134.88M74.12M119.86M117.03M136.38M
Operating Income91.45M46.71M50.58M109.84M63.08M85.82M52.30M50.68M247.31M81.44M36.15M-45.68M46.57M84.49M
Operating Margin20.36%11.71%13.28%20.48%13.08%16.88%10.61%9.76%28.51%10.31%4.90%-6.28%5.63%10.00%
EBITDA87.02M85.35M69.65M127.26M104.46M129.48M91.89M112.23M298.04M156.70M108.77M28.58M125.12M158.44M
EBITDA Margin19.37%21.40%18.29%23.72%21.67%25.46%18.65%21.62%34.36%19.84%14.74%3.93%15.12%18.76%
Net Income52.36M54.59M43.79M86.70M60.94M72.61M44.54M47.03M197.44M75.76M31.48M-54.06M29.42M62.16M
Net Income Margin11.65%13.69%11.50%16.16%12.64%14.28%9.04%9.06%22.76%9.59%4.27%-7.43%3.56%7.36%
R&D23.15M18.03M21.04M26.62M23.91M22.88M21.39M27.90M35.69M39.64M37.42M42.92M43.76M53.67M
R&D as % of Total Revenue5.15%4.52%5.52%4.96%4.96%4.50%4.34%5.37%4.11%5.02%5.07%5.90%5.29%6.36%
Interest Expense10.56M11.11M6.05M5.75M4.28M15.12M6.46M11.32M4.97M6.53M4.86M1.83M2.29M908.93K
Interest Expense % of Total Revenue2.35%2.79%1.59%1.07%0.89%2.97%1.31%2.18%0.57%0.83%0.66%0.25%0.28%0.11%

Balance Sheet

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets507.42M505.09M548.27M624.13M741.37M985.98M1.25B1.53B1.70B1.76B1.66B1.72B1.79B2.20B
Total Liabilities321.43M224.00M223.40M185.05M301.35M217.27M424.29M620.88M375.80M427.84M311.76M449.20M501.34M583.75M
Total Equity154.04M281.09M324.87M439.09M440.02M768.71M791.25M883.81M1.30B1.32B1.33B1.25B1.26B1.58B
Cash72.08M132.89M63.06M108.56M176.19M294.53M301.27M327.47M461.31M514.75M320.72M323.72M315.62M457.67M
Total Debt128.80M125.75M110.25M45.00M92.50M60.00M137.35M350.25M115.23M157.17M33.54M237.99M261.52M-
Net Debt56.72M-7.14M47.19M-63.56M-83.69M-234.53M-163.92M22.78M-346.08M-357.57M-287.18M-85.28M-54.10M-

Cash Flow

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow110.08M105.28M34.40M148.07M73.00M95.33M88.69M58.55M333.20M74.46M40.72M64.42M147.88M138.88M
Investing Cash Flow-105.78M-23.85M-79.57M-42.74M-51.96M-139.48M-82.66M-248.76M-122.16M2.55M-88.33M-241.52M-184.37M-
Financing Cash Flow-12.47M-9.25M-21.10M-72.35M42.51M158.01M9.45M214.59M-52.07M-22.72M-156.88M176.98M-9.35M-
Capital Expenditure96.32M22.72M22.93M21.44M53.77M46.88M144.52M185.88M85.15M99.96M63.26M245.93M169.85M145.68M
Free Cash Flow13.76M82.56M11.48M126.63M19.23M48.45M-55.83M-127.33M248.05M-25.50M-22.54M-181.51M-21.97M-6.80M
Dividends Paid32.96M79.09M5.60M6.10M3.89M64.98M26.45M13.44M14.67M59.92M23.97M10.27M18.07M7.81M
FCF to OCF12.50%78.42%33.36%85.52%26.34%50.82%-62.95%-217.45%74.44%-34.25%-55.36%-281.75%-14.86%-4.89%
Dividend Paid to FCF239.55%95.80%48.78%4.81%20.23%134.11%-47.38%-10.56%5.92%-234.95%-106.32%-5.66%-82.26%-114.93%

Earnings

Report DateOct 24, 2017Dec 31, 2017Apr 23, 2018Aug 17, 2018Oct 20, 2018Mar 19, 2019Apr 26, 2019Aug 18, 2019Oct 25, 2019Dec 31, 2019Apr 27, 2020Aug 29, 2020Oct 27, 2020Dec 31, 2020Apr 27, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023
EPS Estimate-----------------------
EPS Actual0.100.100.150.080.09-0.050.090.130.070.020.020.370.27-0.020.140.140.090.070.120.110.04-0.080.02
Surprise-----------------------
TimingAfter-hours-After-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-market-Pre-marketPre-marketAfter-hours-After-hours--------

Key Statistics & Ratios

Market Cap2.57B
Enterprise Value2.26B
Trailing P/E56.71
Forward P/E0.00
Price / Sales3.09
Price / Book1.58
EPS0.24
Book Value8.47
Revenue (TTM)832.86M
Gross Profit (TTM)206.36M
EBITDA136.38M
Profit Margin5.39%
Operating Margin7.83%
Return on Equity3.32%
Return on Assets1.62%
Shares Outstanding189.03M
Shares Float91.12M
Beta0.33
Dividend Yield0.73%
Dividend Rate0.10
Payout Ratio41.67%

Dividends

20231×
0.06May 25, 2023
20221×
0.14Jun 10, 2022
20211×
0.35Jun 3, 2021
20201×
0.12Jun 8, 2020
20191×
0.09May 23, 2019
20181×
0.20Jun 8, 2018

Stock Splits

  • Jun 8, 20207:5
  • Jun 8, 20187:5